Idogen Running Out Of Survival Options

Swedish Firm Seeking Reverse Merger Solution

With very little cash left in the bank, Idogen is weighing up its options including a reverse merger or liquidation.

Padlock
Idogen faces closure if reverse merger efforts fail • Source: Shutterstock

The future of Idogen AB hangs in the balance with the Swedish firm's critical financial situation leaving its lead clinical-stage development program IDO 8 for hemophilia in limbo.

Idogen's announcement on 28 April that its "work with capitalization has not yet produced the desired result" is quite an...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business